---
title: "Humira (adalimumab) in rheumatoid arthritis: Pharmacology questions"
description: "Pharmacology questions on Humira (adalimumab) in rheumatoid arthritis, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: Mechanism and Pharmacokinetics. Questions: Does Humira lower CRP and ESR in rheumatoid arthritis? What are Humira blood levels in RA with and without methotrexate? 2 questions quoted from 1 source."
canonical: "https://www.evicenter.com/medical-information/humira--rheumatoid-arthritis/pharmacology"
published: "2026-11-14T00:11:41-05:00"
modified: "2026-11-14T01:54:55-05:00"
---

# Humira (adalimumab) in rheumatoid arthritis: Pharmacology questions

Manufacturer: AbbVie Inc.  
Prescribing information: [Humira](https://www.rxabbvie.com/pdf/humira.pdf)

Pharmacology questions that apply to every indication of Humira are on [Humira (adalimumab), all indications: Pharmacology](https://www.evicenter.com/medical-information/humira/pharmacology).

## Mechanism

<a id="humira-ra-crp-esr"></a>

### Does Humira lower CRP and ESR in rheumatoid arthritis?

> “After treatment with HUMIRA, a decrease in concentrations of acute phase reactants of 
> inflammation (C-reactive protein [CRP] and erythrocyte sedimentation rate [ESR]) and serum 
> cytokines (IL-6) was observed compared to baseline in patients with rheumatoid arthritis.”

Source: [HUMIRA: Prescribing information, page 29, captured 2026-11-13](https://www.rxabbvie.com/pdf/humira.pdf#page=29)

## Pharmacokinetics

<a id="humira-ra-blood-levels"></a>

### What are Humira blood levels in RA with and without methotrexate?

> “Rheumatoid Arthritis and Ankylosing Spondylitis: In patients receiving 40 mg HUMIRA every 
> other week, adalimumab mean steady-state trough concentrations were approximately 5 mcg/mL 
> and 8 to 9 mcg/mL, without and with MTX concomitant treatment, respectively. Adalimumab 
> concentrations in the synovial fluid from five rheumatoid arthritis patients ranged from 31 to 
> 96% of those in serum.”

Source: [HUMIRA: Prescribing information, page 30, captured 2026-11-13](https://www.rxabbvie.com/pdf/humira.pdf#page=30)

## Related pages
- [Medical information: Humira (adalimumab): Rheumatoid arthritis](https://www.evicenter.com/medical-information/humira--rheumatoid-arthritis)
- [Indication](https://www.evicenter.com/medical-information/humira--rheumatoid-arthritis/indication)
- [Clinical trials](https://www.evicenter.com/medical-information/humira--rheumatoid-arthritis/clinical-trials)
- [Safety](https://www.evicenter.com/medical-information/humira--rheumatoid-arthritis/safety)
- [Specific populations](https://www.evicenter.com/medical-information/humira--rheumatoid-arthritis/specific-populations)
- [Drug interactions](https://www.evicenter.com/medical-information/humira--rheumatoid-arthritis/drug-interactions)
- [Dosing and administration](https://www.evicenter.com/medical-information/humira--rheumatoid-arthritis/dosing-and-administration)
- [Access and coverage](https://www.evicenter.com/medical-information/humira--rheumatoid-arthritis/access-and-coverage)
